BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today announced the appointment of John J. Howarth to Vice President, Investor Relations. Mr. Howarth joins King with over 25 years of experience in the healthcare industry, including executive positions at specialty pharmaceutical companies, as well as large global pharmaceutical companies.
